Skip to content

The single-shot interscalene brachial plexus block for shoulder pain after lung lobectomy.

The single-shot interscalene brachial plexus block for shoulder pain after lung lobectomy.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0001726
Enrollment
44
Registered
2015-12-10
Start date
2015-12-10
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : Patients will be assigned randomly to either the control group or the interscalene brachial plexus block (ISBPB) group according to a computer-generated randomization table. Before

Sponsors

Ewha Womans University Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: American society of Anesthesiologists physical status class I-III, lung cancer, Patients who are scheduled to undergo elective thoracotomy and to be managed with continuous thoracic paravertebral block for postoperative pain control, Informed consent

Exclusion criteria

Exclusion criteria: any physical or mental illness rendering the patient unable to perform spirometry, respiratory diffuculty at rest,contralateral diaphragmatic paralysis,preexisted ipsilateral shoulder pain, presence of coagulopathy, severe chronic obstructive pulmonary disease, neurologic deficit, infection at the site of the block, drug or alcohol abuse, chronic pain, peptic ulcer disease, uncontrolled diabetes mellitus and a known allergy to local anesthetic, previous thoracic surgery, patient refusal,

Design outcomes

Primary

MeasureTime frame
Incidence and severity of postthoracotomy ipsilateral shoulder pain

Secondary

MeasureTime frame
degree of op site pain;postoperative complications;Pulmonary function test

Countries

Korea, Republic of

Contacts

Public ContactJae Hee Woo

Ewha Womans University Medical Center

shymoon83@gmail.com+82-2-2650-5836

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026